Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapies. [electronic resource]
Producer: 20171016Description: 1732-1738 p. digitalISSN:- 1349-7006
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- administration & dosage
- Cancer Vaccines -- administration & dosage
- Carcinoma, Hepatocellular -- mortality
- Chemoembolization, Therapeutic
- Combined Modality Therapy
- Drug Resistance, Neoplasm
- Feasibility Studies
- Female
- Humans
- Kaplan-Meier Estimate
- Liver Neoplasms -- mortality
- Male
- Middle Aged
- Niacinamide -- administration & dosage
- Phenylurea Compounds -- administration & dosage
- Precision Medicine
- Sorafenib
- T-Lymphocytes, Cytotoxic -- physiology
- Treatment Outcome
- Vaccination
- Vaccines, Subunit -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.